RWP
ABBV icon

Ridgecrest Wealth Partners’s AbbVie ABBV Stock Holding History

Ridgecrest Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Buy
8,339
+1
+0% +$215 1.01% 21
2026
Q1 		$1.81M Hold
8,338
– – 1% 23
2025
Q4 		$1.91M Buy
8,338
+86
+1% +$19.6K 1.03% 23
2025
Q3 		$1.91M Buy
8,252
+2
+0% +$407 0.86% 25
2025
Q2 		$1.53M Sell
8,250
-3
-0% -$558 0.81% 29
2025
Q1 		$1.73M Buy
8,253
+350
+4% +$68K 0.91% 26
2024
Q4 		$1.4M Hold
7,903
– – 0.76% 28
2024
Q3 		$1.56M Buy
7,903
+198
+3% +$37K 0.81% 24
2024
Q2 		$1.32M Buy
7,705
+34
+0.4% +$5.63K 0.8% 27
2024
Q1 		$1.4M Hold
7,671
– – 0.83% 27
2023
Q4 		$1.19M Sell
7,671
-519
-6% -$75.7K 0.79% 31
2023
Q3 		$1.22M Hold
8,190
– – 0.86% 28
2023
Q2 		$1.1M Hold
8,190
– – 0.73% 28
2023
Q1 		$1.31M Hold
8,190
– – 0.93% 24
2022
Q4 		$1.32M Hold
8,190
– – 1.01% 24
2022
Q3 		$1.1M Sell
8,190
-3,150
-28% -$452K 0.9% 26
2022
Q2 		$1.74M Hold
11,340
– – 1.26% 22
2022
Q1 		$1.84M Hold
11,340
– – 1.17% 20
2021
Q4 		$1.53M Buy
11,340
+74
+0.7% +$8.74K 0.75% 32
2021
Q3 		$1.22M Buy
11,266
+576
+5% +$65.8K 0.66% 36
2021
Q2 		$1.2M Buy
10,690
+2,400
+29% +$270K 0.75% 35
2021
Q1 		$897K Buy
+8,290
New +$887K 0.86% 37

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ridgecrest Wealth Partners's ABBV Position: Q2 2026 in Review

Ridgecrest Wealth Partners increased its AbbVie (ABBV) stake by 0.01% in Q2 2026, buying an estimated $215 and bringing the position to 8,339 shares worth $2.1M. The position accounts for 1.01% of the portfolio, ranked #21.

Ridgecrest Wealth Partners first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ridgecrest Wealth Partners held 8,339 shares of AbbVie worth $2.1M as of Q2 2026.
  • Ridgecrest Wealth Partners bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 1.01% of Ridgecrest Wealth Partners's portfolio in Q2 2026, its #21 holding.
  • Ridgecrest Wealth Partners first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ridgecrest Wealth Partners's 13F filing for Q2 2026, filed 5 Aug 2026.